Fletcher CDM, World Health Organization, International Agency for Research on Cancer, editors. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013. 468 (World Health Organization classification of tumours).

Dockhorn-Dworniczak B, Schäfer KL, Dantcheva R, Blasius S, Winkelmann W, Strehl S, et al. Diagnostic value of the molecular genetic detection of the t(11;22) translocation in Ewing’s tumours. Virchows Arch Int J Pathol. 1994;425:107–12.

Article  CAS  Google Scholar 

Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, et al. The Ewing family of tumors–a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N. Engl J Med. 1994;331(Aug 4):294–9.

Article  CAS  PubMed  Google Scholar 

Kovar H, Dworzak M, Strehl S, Schnell E, Ambros IM, Ambros PF, et al. Overexpression of the pseudoautosomal gene MIC2 in Ewing’s sarcoma and peripheral primitive neuroectodermal tumor. Oncogene. 1990;5(Jul):1067–70.

CAS  PubMed  Google Scholar 

Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature. 1992;359:162–5.

Article  CAS  PubMed  Google Scholar 

Zoubek A, Dockhorn-Dworniczak B, Delattre O, Christiansen H, Niggli F, Gatterer-Menz I, et al. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol J Am Soc Clin Oncol. 1996;14:1245–51.

Article  CAS  Google Scholar 

Juergens C, Weston C, Lewis I, Whelan J, Paulussen M, Oberlin O, et al. Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial. Pediatr Blood Cancer. 2006;47:22–9.

Article  PubMed  Google Scholar 

Le Deley MC, Delattre O, Schaefer KL, Burchill SA, Koehler G, Hogendoorn PCW, et al. Impact of EWS-ETS fusion type on disease progression in Ewing’s sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial. J Clin Oncol J Am Soc Clin Oncol. 2010;28:1982–8.

Article  Google Scholar 

Franzius C, Sciuk J, Daldrup-Link HE, Jürgens H, Schober O. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med. 2000;27:1305–11.

Article  CAS  PubMed  Google Scholar 

Györke T, Zajic T, Lange A, Schäfer O, Moser E, Makó E, et al. Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours. Nucl Med Commun. 2006;27:17–24.

Article  PubMed  Google Scholar 

Völker T, Denecke T, Steffen I, Misch D, Schönberger S, Plotkin M, et al. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol J Am Soc Clin Oncol. 2007;25:5435–41.

Article  Google Scholar 

Campbell KM, Shulman DS, Grier HE, DuBois SG. Role of bone marrow biopsy for staging new patients with Ewing sarcoma: a systematic review. Pediatr Blood Cancer. 2021;68:e28807.

Article  PubMed  Google Scholar 

Guinot A, Tabone-Eglinger S, Isnardi V, Bahri H, Surdez D, Delattre O, et al. Staging of newly diagnosed Ewing sarcoma: Results of bone marrow aspiration and biopsy versus (18)FDG-PET/CT imaging for bone marrow involvement. Eur J Cancer Oxf Engl 1990. 2023;179:56–64.

CAS  Google Scholar 

Le Deley MC, Paulussen M, Lewis I, Brennan B, Ranft A, Whelan J, et al. Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial. J Clin Oncol J Am Soc Clin Oncol. 2014;32:2440–8.

Article  Google Scholar 

Womer RB, West DC, Krailo MD, Dickman PS, Pawel BR, Grier HE, et al. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children’s Oncology Group. J Clin Oncol J Am Soc Clin Oncol. 2012;30:4148–54.

Article  CAS  Google Scholar 

Ladenstein R, Pötschger U, Le Deley MC, Whelan J, Paulussen M, Oberlin O, et al. Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. J Clin Oncol J Am Soc Clin Oncol. 2010;28:3284–91.

Article  CAS  Google Scholar 

Oberlin O, Rey A, Desfachelles AS, Philip T, Plantaz D, Schmitt C, et al. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l’Enfant. J Clin Oncol J Am Soc Clin Oncol. 2006;24:3997–4002.

Article  CAS  Google Scholar 

Gupta A, Riedel RF, Shah C, Borinstein SC, Isakoff MS, Chugh R, et al. Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor Board. Cancer. 2023;129:3363–71.

Article  PubMed  Google Scholar 

Strauss SJ, Frezza AM, Abecassis N, Bajpai J, Bauer S, Biagini R, et al. Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol J Eur Soc Med Oncol. 2021;32:1520–36.

Article  CAS  Google Scholar 

Haeusler J, Ranft A, Boelling T, Gosheger G, Braun-Munzinger G, Vieth V, et al. The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES). Cancer. 2010;116:443–50.

Article  PubMed  Google Scholar 

Karimi AM, Campbell SR, Parsai S, Angelov L, Scott J, Qi P, et al. Aggressive local control with multisite stereotactic body radiation in metastatic ewing sarcoma: a literature review and case report. Anticancer Res. 2020;40:951–5.

Article  PubMed  Google Scholar 

Chan BY, Gill KG, Rebsamen SL, Nguyen JC. MR imaging of pediatric bone marrow. Radiogr Rev Publ Radio Soc N. Am Inc. 2016;36:1911–30.

Google Scholar 

Du Y, Zhao Z, Yang C. Is bone marrow biopsy and aspiration still mandatory when 18F-FDG PET/CT is available for the initial assessment of bone marrow metastasis in pediatric Ewing sarcoma? Front Oncol. 2024;14:1372481.

Article  PubMed  PubMed Central  Google Scholar